Sana Biotechnology Public
Sana is creating engineered cells to repair and control genes in cells or replace missing or damaged cells to solve the underlying causes of disease.
Investors
%20.jpg)
Estimated Revenue:
$1M to $10M
Technology:
Drug Delivery
Industry:
PharmTech
Last Funding Type:
Venture - Series Unknown
Total Funding:
$2M
Funding Status:
IPO
Headquarters:
Seattle, Washington, United States
Investors Number:
2
Founded Date:
2018
Employee Number:
101-250